Search for: "Lillie Johnson"
Results 221 - 240
of 242
Sorted by Relevance
|
Sort by Date
2 Aug 2014, 6:05 am
Johnson, 70 Ill. [read post]
3 Nov 2022, 5:12 am
Carrie Johnson reports for NPR. [read post]
1 Feb 2013, 9:42 am
Every now and then we run into a decision that we think is wrong in so many different ways that we call it an example of “spherical error” – that is, error no matter how one looks at it. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
3 May 2014, 8:56 am
After a long winter, the cherry trees are finally managing to blossom. [read post]
21 Jul 2008, 2:41 pm
Pugh stepped down after receiving 49.9 percent opposition, while Stever and director Charles Lillis received more than 40 percent negative votes. [read post]
12 Jun 2023, 1:09 pm
In scientific publishing, when scientists make a mistake, they publish an erratum or a corrigendum. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
10 Feb 2023, 4:44 am
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
28 Oct 2011, 7:00 am
Johnson & Johnson, 2011 WL 2003407, at *5 (E.D. [read post]
29 Jan 2024, 4:35 pm
Pix credit hereCates 1980 has distributed its February 2024 Report. [read post]
17 Mar 2020, 1:32 pm
NEUTROGENA® and AVEENO® Aerosol Sunscreen Products have been recalled by Johnson & Johnson Consumer Inc. due to the presence of benzene. [read post]
8 May 2020, 3:00 am
National/Federal Both Parties Wonder: How much do conventions even matter anymore? [read post]
18 Feb 2010, 10:34 am
This post is about un-preempted fraud on the FDA claims and how to approach them…. [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 Jan 2008, 3:06 am
Johnson Outdoors, Inc, filed 03/14/07 closed 07/25/07 1:07-cv-01490 Electronic Imaging Systems of America, Inc. v. [read post]
18 Dec 2008, 10:36 pm
Eli Lilly & Co., 99 F.R.D. 126, 128 (D.D.C. 1983)). [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
